Skip to main content
Boryung Corporation logo

Boryung Corporation — Investor Relations & Filings

Ticker · 003850 ISIN · KR7003850005 KO Manufacturing
Open in API
Filings indexed 354 across all filing types
Latest filing 2021-03-04 AGM Information
Country KR South Korea
Listing KO 003850

About Boryung Corporation

https://pharm.boryung.co.kr/eng/index.do

Boryung Corporation is a fully integrated healthcare company founded in 1957. Its core business encompasses the research, development, manufacturing, and global commercialization of pharmaceutical products, with a significant presence in the cardiovascular therapeutic area. The company is distinguished by its pioneering 'Care in Space' (CIS) initiative, which focuses on developing healthcare solutions for humans in extreme environments and leveraging space for new research opportunities. In addition to its pharmaceutical operations, Boryung functions as a healthcare investment company, fostering innovation across the health sector. The company's diverse portfolio includes prescription drugs, over-the-counter products, and a pipeline aimed at addressing future medical needs.

Recent filings

Filing Released Lang Actions
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Boryung Pharmaceutical. It contains the agenda for the upcoming Annual General Meeting (AGM), including items such as the approval of financial statements, election of directors, and dividend proposals. It also includes detailed management information, governance disclosures (board activities), and financial statements (balance sheet, income statement, etc.) as required by Korean regulatory standards for shareholder meeting notices. Since this document serves as the official proxy and information statement sent to shareholders to request their votes for the AGM, it is classified as a Proxy Solicitation & Information Statement.
2021-03-04 Korean
주주총회집중일개최사유신고
AGM Information Classification · 95% confidence The document is a formal notification filed with the Korea Exchange (KRX) regarding the scheduling of a General Meeting of Shareholders on a 'concentrated date' (a date when many companies hold their meetings). It explains the operational reasons for this scheduling and references related disclosures like the notice of convocation. Since it is a regulatory disclosure regarding meeting logistics rather than the meeting materials themselves or a proxy statement, it falls under the general regulatory filing category.
2021-03-04 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Boryung Pharmaceutical regarding the decision to pay cash dividends. It specifies the dividend amount per share, the total dividend amount, the record date, and the date of the board resolution. This fits the definition of a 'Notice of Dividend Amount' (DIV) as it provides specific details regarding dividend payments to shareholders.
2021-02-25 Korean
[연장결정]주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Korean financial authorities regarding a decision to enter into a trust agreement for the acquisition of treasury shares (자기주식취득 신탁계약 체결 결정). It details the contract period, the financial limits for the acquisition, and the current status of treasury share holdings. This type of filing specifically relates to a company's decision to buy back its own shares through a trust, which falls under the 'Transaction in Own Shares' category.
2021-02-25 Korean
[연장결정]주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Korean financial authorities regarding a decision to enter into or extend a trust agreement for the acquisition of treasury shares (자기주식취득 신탁계약 체결 결정). This type of filing is a specific regulatory disclosure concerning a company's capital structure and share repurchase activities. According to the provided definitions, 'Transaction in Own Shares' (POS) is the most accurate category for reports detailing share buybacks or related trust agreements.
2021-02-25 Korean
[연장결정]주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares Classification · 100% confidence The document is a formal regulatory filing titled '주요사항보고서' (Major Report) regarding the decision to enter into a trust agreement for the acquisition of treasury shares (자기주식취득 신탁계약 체결 결정). It details the contract terms, board resolution dates, and current shareholding status. This falls under the category of company share buyback or treasury share transactions, which is classified as 'Transaction in Own Shares' (POS).
2021-02-25 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.